Virtu Financial’s Tevogen Bio Holdings TVGN Stock Holding History

Virtu Financial’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-426	Closed	-$7K	–	2408
2025 Q4	$7K	Buy	426 +137	+47%	+$3.56K	﹤0.01%	1537
2025 Q3	$11K	Buy	+289	New	+$14.2K	﹤0.01%	1339
2023 Q1	–	Sell	-256	Closed	-$132K	–	2181
2022 Q4	$132K	Sell	256 -38	-13%	-$19.4K	0.02%	859
2022 Q3	$149K	Buy	+294	New	+$148K	0.01%	977

Other funds holding TVGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Virtu Financial's TVGN Position: Q1 2026 in Review

Virtu Financial sold out of Tevogen Bio Holdings (TVGN) in Q1 2026, closing a stake of 426 shares — an estimated $7K sold.

Virtu Financial first reported a position in TVGN in Q3 2022 and held it in 4 quarters. The position peaked at $149K in Q3 2022. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

Virtu Financial reported no remaining Tevogen Bio Holdings position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 426 Tevogen Bio Holdings shares in Q1 2026, an estimated $7K.
Virtu Financial first reported a position in Tevogen Bio Holdings in Q3 2022 and held it in 4 quarters.
Virtu Financial's Tevogen Bio Holdings position peaked at $149K in Q3 2022.
30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.